What is the prevalence of allergic rhinosinusitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Allergic rhinosinusitis affects approximately 10% to 40% of the population, as stated in the most recent and highest quality study available 1. The prevalence of allergic rhinosinusitis varies significantly by geographic region, with higher rates typically observed in westernized countries. Some key points to consider include:

  • The condition is increasing in prevalence, particularly in developing countries adopting western lifestyles, due to environmental factors such as increased air pollution and reduced early childhood exposure to diverse microorganisms (the hygiene hypothesis) 1.
  • Genetic factors also play a significant role, with a increased risk in individuals with a family history of allergies 1.
  • The condition typically begins in childhood or early adulthood, with peak prevalence occurring between ages 10-30, though it can develop at any age 1.
  • The substantial prevalence of allergic rhinosinusitis represents a significant healthcare burden, affecting quality of life and productivity for millions worldwide, with estimated direct medical costs of $7.3 billion for the year 2002 1. Some other relevant information includes:
  • Allergic rhinitis may be classified by the temporal pattern of exposure to a triggering allergen as seasonal, perennial/year round, or episodic 1.
  • The symptoms of allergic rhinitis result from a complex allergen-driven mucosal inflammation caused by interplay 1.
  • The financial impact on society is tremendous, with the estimated cost of allergic rhinitis based on direct and indirect costs being $11.58 billion for 2002 1.

From the Research

Prevalence of Allergic Rhinosinusitis

  • The prevalence of allergic rhinitis, a key component of allergic rhinosinusitis, is estimated to range from 4% to over 40% in various populations 2.
  • A study in Oman found the prevalence of allergic rhinitis to be 7% among adults presenting with nasal symptoms, with females being more affected than males 3.
  • In the United States, the prevalence of allergic rhinitis is increasing, with contributing factors possibly including higher concentrations of airborne pollution, rising dust mite populations, and less ventilation in homes and offices 2.
  • Perennial allergens, such as house dust mites and molds, play a more significant role in chronic and recurrent acute rhinosinusitis than seasonal allergens 4.
  • The prevalence of allergic fungal rhinosinusitis, a specific type of allergic rhinosinusitis, is estimated to be around 6-9% among all rhinosinusitis cases requiring surgery 5.
  • A study in Belgium found the overall prevalence of allergic rhinitis to be 30.9%, with symptomatic sensitization related to trees, grass, and house dust mites reported in 9.7%, 17.6%, and 17.1% of cases, respectively 6.
  • The prevalence of allergic sensitization, as measured by skin prick tests, was found to be 40.3% in the Belgian population, with a peak in the third and fourth decades of life 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Allergic rhinitis: epidemiology and natural history.

Allergy and asthma proceedings, 2000

Research

Prevalence of allergy in patients with chronic rhinosinusitis.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2004

Research

The prevalence of allergic fungal rhinosinusitis in sinonasal polyposis.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.